Published March, 2018
By Meletios A. Dimopoulos, Thierry Facon and Evangelos Terpos
Publisher: Springer (Springer International Publishing AG)
Series: Hematologic Malignancies
Rating:
Availability: Available

Key features include the provision of new criteria for the diagnosis of symptomatic multiple myeloma requiring treatment and the description of novel therapies for myeloma and other plasma cell neoplasms that have only very recently been licensed by the U.S. Food and Drug Administration.

---

Published February, 2015
By Andreas Engert and Anas Younes
Publisher: Springer (Springer International Publishing)
Series: Hematologic Malignancies
Rating:
Availability: Not available (reason unspecified)

---

Published December, 2014
By Junia V. Melo, J.V. Melo, J. Goldman and J V Melo
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Hematologic Malignancies
Rating:
Availability: Available

This book contains a series of contributions from internationally renowned academics with special expertise in one or other diseases which collectively are grouped under the heading myeloproliferative disorders. A feature of this book is the speed with which it has been produced - an important factor in this rapidly moving field.

---

Published December, 2014
By Hagop M. Kantarjian, Elihu H. Estey, Stefan H. Faderl, S.H. Faderl and H.M. Kantarjian
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Hematologic Malignancies
Rating:
Availability: Available

Better therapy of acute leukemias depends ultimately on better understanding of the distinction between leukemic and normal progenitor cells. This hugely important new book describes the current knowledge of acute leukemia biology and discusses new classification systems that have arisen as a result of emerging insights into pathogenesis.

---

Published February, 2014
By Michael Williams, Michael E. Williams and Martin Dreyling
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Hematologic Malignancies
Rating:
Availability: Available

After a decade of tremendous progress in the diagnostic and therapeutic approaches to malignant lymphoma, optimal treatment strategies are now based not only on accurate diagnosis but also on thorough evaluation of clinical and molecular risk factors.

---

Published July, 2013
By Torsten Haferlach, H. Joachim Deeg, David T. Bowen, Steven D. Gore, Michelle M. Le Beau and Charlotte Niemeyer
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Hematologic Malignancies
Rating:
Availability: Available

The diagnosis of myelodysplastic syndromes (MDS), a heterogeneous group of clonal hematopoietic disorders, is being made with increasing frequency over the past decade owing to increased recognition, improved understanding, and an aging population.

---

Published February, 2012
By Ayalew Tefferi and Tiziano Barbui
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Hematologic Malignancies
Rating: 1.00
Availability: Available

Myeloproliferative neoplasms (MPNs) are clonal stem cell diseases that the WHO subcategorizes into eight clinicopathologic entities. This invaluable resource focuses on three of these: polycythemia vera, essential thrombocythemia, and primary myelofibrosis.

---

Published December, 2010
By Morie A. Gertz and Philip R. Greipp
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Hematologic Malignancies
Rating:
Availability: Available

with contributions by numerous experts

---

Published October, 2010
By Andreas Engert and Sandra J. Horning
Publisher: Springer (Springer-Verlag Berlin and Heidelberg GmbH & Co. K)
Series: Hematologic Malignancies
Rating:
Availability: Contact supplier

This comprehensive and up-to-date account of Hodgkin lymphoma examines epidemiology, pathogenesis and the role of the microenvironment. Discussion includes treatment options for first-line and recurrent cases, and individually tailored treatment strategies.

---

Published November, 2007
By Elihu H. Estey, Stefan H. Faderl, Hagop Kantarjian, S.H. Faderl and H.M. Kantarjian
Publisher: Springer (Springer Berlin Heidelberg)
Series: Hematologic Malignancies
Rating:
Availability: Not available (reason unspecified)

Better therapy of acute leukemias depends ultimately on better understanding of the distinction between leukemic and normal progenitor cells. This hugely important new book describes the current knowledge of acute leukemia biology and discusses new classification systems that have arisen as a result of emerging insights into pathogenesis.

---